More on SLN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.3 Score)
- Holders

Upcoming Events

- Earnings (8/14/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Silence Therapeutics (NQ:SLN)
Delayed: 6.23 +0.73 (13.27%)
Prev. Close $5.50  
Open$5.44 
52 Wk High$0.27 
52 Wk Low$0.18 
Day High$6.29 
Day Low$5.31 
P/E N/A  
EPS$-0.44 
Volume313,182 

Friends, Peers and Foes (?): SLNCF (more...)

Mar 5, 2026 04:06 PM Form S-8 Silence Therapeutics
Mar 5, 2026 11:42 AM Jefferies Reiterates Buy Rating on Silence Therapeutics (SLN): "looks cheap at $175M+ EV"
Mar 5, 2026 07:50 AM Form 10-K Silence Therapeutics For: Dec 31
Mar 5, 2026 07:41 AM Form 8-K Silence Therapeutics For: Mar 05
Mar 5, 2026 07:30 AM Silence Therapeutics Highlights Recent Business Achievements and Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 2, 2026 03:06 PM William Blair Reiterates Outperform Rating on Silence Therapeutics (SLN)
Feb 13, 2026 06:11 AM Form 4 Silence Therapeutics For: Aug 03 Filed by: Griffiths Richard Ian
Feb 9, 2026 01:17 PM Form SCHEDULE 13G/A Silence Therapeutics Filed by: Lombard Odier Asset Management (USA) Corp
Feb 4, 2026 05:30 PM Form 8-K Southland Holdings, Inc. For: Feb 04
Jan 23, 2026 06:50 AM H.C. Wainwright Reiterates Buy Rating on Silence Therapeutics (SLN)
View All Articles

Entities mentioned with SLN

View All Entities